Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Jukema, JW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 61 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mulder, HJGH; Schalij, MJ; Kauer, B; Visser, RF; van Dijkman, PRM; Jukema, JW; Zwinderman, AH; Bruschke, AVG
      Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial

      HEART
    2. van Geel, PP; Pinto, YM; Zwinderman, AH; Henning, RH; van Boven, A; Jukema, JW; Bruschke, AVG; Kastelein, JJP; van Gilst, WH
      Increased risk for ischaemic events is related to combined RAS polymorphism

      HEART
    3. van de Poll, SWE; Romer, TJ; Volger, OL; Delsing, DJM; Schut, TCB; Princen, HMG; Havekes, LM; Jukema, JW; van der Laarse, A; Puppels, GJ
      Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Steendijk, P; Staal, E; Jukema, JW; Baan, J
      Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    5. Nederhand, RJ; de Maat, MPM; Jukema, JW
      Factor VII polymorphisms and myocardial infarction: What is special in italians?

      THROMBOSIS AND HAEMOSTASIS
    6. Agema, WRP; Jukema, JW; Pimstone, SN; Kastelein, JJP
      Genetic aspects of restenosis after percutaneous coronary interventions - Towards more tailored therapy

      EUROPEAN HEART JOURNAL
    7. Langerak, SE; Kunz, P; Vliegen, HW; Lamb, HJ; Jukema, JW; van der Wall, EE; de Roos, A
      Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress

      RADIOLOGY
    8. Clee, SM; Zwinderman, AH; Engert, JC; Zwarts, KY; Molhuizen, HOF; Roomp, K; Jukema, JW; van Wijland, M; van Dam, M; Hudson, TJ; Brooks-Wilson, A; Genest, J; Kastelein, JJ; Hayden, MR
      Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

      CIRCULATION
    9. Delsing, DJM; Offerman, EH; van Duyvenvoorde, W; van der Boom, H; de Wit, ECM; Gijbels, MJJ; van der Laarse, A; Jukema, JW; Havekes, LM; Princen, HMG
      Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice

      CIRCULATION
    10. de Man, FH; Weverling-Rijnsburger, AWE; van der Laarse, A; Smelt, AHM; Jukema, JW; Blauw, GJ
      Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation - Reversal after lipid-lowering therapy by atorvastatin

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. Oemrawsingh, PV; Schalij, MJ; Srimahachota, S; Jukema, JW; Bruschke, AVG
      Clinical and angiographic outcome of stent implantation without predilatation using the Jostent Flex stent

      JOURNAL OF INVASIVE CARDIOLOGY
    12. Lievers, KJA; Mennen, LI; Rattink, AP; Zwinderman, AH; Jukema, JW; Schouten, EG; de Maat, MPM
      The-323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men

      THROMBOSIS RESEARCH
    13. Kastelein, JJP; Jukema, JW; Zwinderman, AH; Clee, S; van Boven, AJ; Jansen, H; Rabelink, TJ; Peters, RJG; Lie, KI; Liu, G; Bruschke, AVG; Hayden, MR
      Lipoprotein lipase activity is associated with severity of angina pectoris

      CIRCULATION
    14. Mulder, HJGH; Bal, ET; Jukema, JW; Zwinderman, AH; Schalij, MJ; van Boven, AJ; Bruschke, AVG
      Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasly (REGRESS trial)

      AMERICAN JOURNAL OF CARDIOLOGY
    15. Hagenaars, T; Gussenhoven, EJ; van Sambeek, MRHM; Jukema, JW; Kranendonk, SE; Bom, N
      Effect of Simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction

      AMERICAN JOURNAL OF CARDIOLOGY
    16. Schalij, MJ; Udayachalerm, W; Oemrawsingh, P; Jukema, JW; Reiber, JHC; Bruschke, AVG
      Stenting of long coronary artery lesions: Initial angiographic results and6-month clinical outcome of the micro stent II-XL

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    17. Jukema, JW
      Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease

      HEART
    18. Bekedam, MA; Vliegen, HW; Doornbos, J; Jukema, JW; de Roos, A; van der Wall, EE
      Diagnosis and management of anomalous origin of the right coronary artery from the left coronary sinus

      INTERNATIONAL JOURNAL OF CARDIAC IMAGING
    19. Henderson, HE; Kastelein, JJP; Zwinderman, AH; Gagne, E; Jukema, JW; Reymer, PWA; Groenemeyer, BE; Lie, KI; Bruschke, AVG; Hayden, MR; Jansen, H
      Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins

      JOURNAL OF LIPID RESEARCH
    20. Hallman, DM; Groenemeijer, BE; Jukema, JW; Boerwinkle, E; Kastelein, JJP
      Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci

      ANNALS OF HUMAN GENETICS
    21. Shepherd, J; Blauw, GJ; Murphy, MB; Cobbe, SM; Bollen, ELEM; Buckley, BM; Ford, I; Jukema, JW; Hyland, M; Gaw, A; Lagaay, AM; Perry, IJ; Macfarlane, PW; Meinders, AE; Sweeney, BJ; Packard, CJ; Westendorp, RGJ; Twomey, C; Scott, DJ
      The design of a Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

      AMERICAN JOURNAL OF CARDIOLOGY
    22. de Maat, MPM; Jukema, JW; Ye, S; Zwinderman, AH; Moghaddam, PH; Beekman, M; Kastelein, JJP; van Boven, AJ; Bruschke, AVG; Humphries, SE; Kluft, C; Henney, AM
      Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

      AMERICAN JOURNAL OF CARDIOLOGY
    23. Jukema, JW; Simoons, ML
      Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"

      ACTA CARDIOLOGICA
    24. DEMAAT MPM; KASTELEIN JJP; JUKEMA JW; ZWINDERMAN AH; JANSEN H; GROENEMEIER B; BRUSCHKE AVG; KLUFT C
      -455G A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE IS ASSOCIATED WITH THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC MEN - PROPOSED ROLE FOR AN ACUTE-PHASE REACTION PATTERN OF FIBRINOGEN/

      Arteriosclerosis, thrombosis, and vascular biology
    25. JUKEMA JW; VANBOVEN AJ; ZWINDERMAN AH; VANDERLAARSE A; BRUSCHKE AVG
      PROPOSED SYNERGISTIC EFFECT OF CALCIUM-CHANNEL BLOCKERS WITH LIPID-LOWERING THERAPY IN RETARDING PROGRESSION OF CORONARY ATHEROSCLEROSIS

      Cardiovascular drugs and therapy
    26. DEGROOT E; JUKEMA JW; VANSWIJNDREGT ADM; ZWINDERMAN AH; ACKERSTAFF RGA; VANDERSTEEN AFW; BOM N; LIE KI; BRUSCHKE AVG
      B-MODE ULTRASOUND ASSESSMENT OF PRAVASTATIN TREATMENT EFFECT ON CAROTID AND FEMORAL-ARTERY WALLS AND ITS CORRELATIONS WITH CORONARY ARTERIOGRAPHIC FINDINGS - A REPORT OF THE REGRESSION GROWTH EVALUATION STATINSTUDY (REGRESS)

      Journal of the American College of Cardiology
    27. ROMER TJ; BUSCHMAN HP; PUPPELS GJ; BRENNAN JF; VANDERLAARSE A; JUKEMA JW; HAVEKES LM; BRUSCHKE AV
      RAMAN-SPECTROSCOPY PROVIDES CHEMICAL MAPPINGS OF ATHEROSCLEROTIC PLAQUES IN APOE-ASTERISK-3 LEIDEN TRANSGENIC MICE

      Journal of the American College of Cardiology
    28. SCHALIJ MJ; SAVALLE LH; TRESUKOSOL D; JUKEMA JW; REIBER JHC; BRUSCHKE AVG
      MICRO-STENT-I, INITIAL RESULTS, AND 6 MONTHS FOLLOW-UP BY QUANTITATIVE CORONARY ANGIOGRAPHY

      Catheterization and cardiovascular diagnosis
    29. KUIVENHOVEN JA; JUKEMA JW; ZWINDERMAN AH; DEKNIJFF P; MCPHERSON R; BRUSCHKE VG; LIE KI; KASTELEIN JJP
      THE ROLE OF A COMMON VARIANT OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE IN THE PROGRESSION OF CORONARY ATHEROSCLEROSIS

      The New England journal of medicine
    30. KASTELEIN JJP; GROENEMEYER BD; HALLMAN DM; HENDERSON H; REYMER PWA; GAGNE SE; JANSEN H; SEIDELL JC; KROMHOUT D; JUKEMA JW; BRUSCHKE AVG; BOERWINKLE E; HAYDEN MR
      THE ASN9 VARIANT OF LIPOPROTEIN-LIPASE IS ASSOCIATED WITH THE -93G PROMOTER MUTATION AND AN INCREASED RISK OF CORONARY-ARTERY DISEASE

      Clinical genetics
    31. DEMAN FH; WEVERLING AW; SMELT AH; VANDERLAARSE A; LEUVEN JAG; JUKEMA JW; BLAUW GJ
      IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN THE FOREARM OF PATIENTS WITH ENDOGENOUS HYPERTRIGLYCERIDEMIA - REVERSAL UPON LIPID-LOWERING THERAPY BY ATORVASTATIN

      Circulation
    32. KASTELEIN JJP; JUKEMA JW; VANBOVEN AJ; JANSEN H; ZWINDERMAN AH; RABELINK TJ; PETERS RJG; LIE KI; BRUSCHKE AVG; HAYDEN MR
      LIPOPROTEIN-LIPASE (LPL) ACTIVITY IS DECREASED IN CAD PATIENTS AND INVERSELY CORRELATED WITH SEVERITY OF ANGINA-PECTORIS AND SILENT-MYOCARDIAL-ISCHEMIA

      Circulation
    33. AENGEVAEREN WRM; VANBOVEN AJ; ZWINDERMAN AH; JUKEMA JW; BRUSCHKE AVG; VANDERWERF T
      FUNCTIONAL-EVALUATION OF LIPID-LOWERING THERAPY BY PRAVASTATIN - RESPONSE

      Circulation
    34. OEMRAWSINGH PV; TUINENBURG JC; SCHALIJ MJ; JUKEMA JW; REIBER JHC; BRUSCHKE AVG
      CLINICAL AND ANGIOGRAPHIC OUTCOME OF MICRO-STENT-II IMPLANTATION IN NATIVE CORONARY-ARTERIES

      The American journal of cardiology
    35. VANBOVEN AJ; JUKEMA JW; HAAKSMA J; ZWINDERMAN AH; CRIJNS HJGM; LIE KI
      DEPRESSED HEART-RATE-VARIABILITY IS ASSOCIATED WITH EVENTS IN PATIENTS WITH STABLE CORONARY-ARTERY DISEASE AND PRESERVED LEFT-VENTRICULAR FUNCTION

      The American heart journal
    36. JANSEN H; VERHOEVEN AJM; WEEKS L; KASTELEIN JJP; HALLEY DJJ; VANDENOUWELAND A; JUKEMA JW; SEIDELL JC; BIRKENHAGER JC
      COMMON C-TO-T SUBSTITUTION AT POSITION--480 OF THE HEPATIC LIPASE PROMOTER ASSOCIATED WITH A LOWERED LIPASE ACTIVITY IN CORONARY-ARTERY DISEASE PATIENTS

      Arteriosclerosis, thrombosis, and vascular biology
    37. COBBAERT C; JUKEMA JW; ZWINDERMAN AH; WITHAGEN AJRM; LINDEMANS J; BRUSCHKE AVG
      MODULATION OF LIPOPROTEIN(A) ATHEROGENICITY BY HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN MIDDLE-AGED MEN WITH SYMPTOMATIC CORONARY-ARTERY DISEASE AND NORMAL TO MODERATELY ELEVATED SERUM-CHOLESTEROL

      Journal of the American College of Cardiology
    38. ZWINDERMAN AH; JUKEMA JW; VANBOVEN AJ; REIBER JHC
      ON THE STATISTICAL MODELING OF CORONARY ARTERIOGRAPHIC DATA - DYNAMICS OF CORONARY ATHEROSCLEROSIS RELATED TO SYSTEMIC AND FOCAL PARAMETERS

      Statistics in medicine
    39. COBBAERT C; JUKEMA JW; ZWINDERMAN AH; WITHAGEN AJAM; BRUSCHKE AVG
      MODULATION OF LIPOPROTEIN(A) ATHEROGENICITY BY SERUM HDL-C IN MIDDLE-AGED MEN WITH SYMPTOMATIC CORONARY-ARTERY DISEASE AND MODERATELY ELEVATED SERUM-CHOLESTEROL

      Atherosclerosis
    40. DEMAAT MPM; JUKEMA JW; YE S; ZWINDERMAN AH; BEEKMAN M; KASTELEIN JJP; BRUSCHKE AVG; HUMPHRIES SE; KLUFT C; HENNEY AM
      STROMELYSIN PROMOTER POLYMORPHISM IS ASSOCIATED WITH THE PROGRESSION OF CORONARY HEART-DISEASE

      Atherosclerosis
    41. JUKEMA JW; DEMAAT MP; YE S; ZWINDERMAN AH; BEEKMAN M; KASTELEIN JJP; VANBOVEN AJ; BRUSCHKE AVG; HUMPHRIES SE; KLUFT C; HENNEY AM
      RISK OF CLINICAL RESTENOSIS AFTER PTCA IS INFLUENCED BY A COMMON FUNCTIONAL VARIANT IN THE HUMAN STROMELYSIN-1 GENE PROMOTER

      Circulation
    42. KLUIJTMANS LAJ; KASTELEIN JJP; LINDEMANS J; BOERS GHJ; HEIL SG; BRUSCHKE AVG; JUKEMA JW; VANDENHEUVEL LPWJ; TRIJBELS FJM; BOERMA GJM; VERHEUGT FWA; WILLEMS F; BLOM HJ
      THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE IN CORONARY-ARTERY DISEASE

      Circulation
    43. VANBOVEN AJ; JUKEMA JW; ZWINDERMAN AH; CRIJNS HJGM; LIE KI; BRUSCHKE AVG
      PRAVASTATIN TREATMENT IN ANGINA-PECTORIS - RESPONSE

      Circulation
    44. AENGEVAEREN WRM; UIJEN GJH; JUKEMA JW; BRUSCHKE AVG; VANDERWERF T
      FUNCTIONAL-EVALUATION OF LIPID-LOWERING THERAPY BY PRAVASTATIN IN THEREGRESSION GROWTH EVALUATION STATIN STUDY (REGRESS)

      Circulation
    45. VLIEGEN HW; DOORNBOS J; DEROOS A; JUKEMA JW; BEKEDAM MA; VANDERWALL EE
      VALUE OF FAST GRADIENT-ECHO MAGNETIC-RESONANCE ANGIOGRAPHY AS AN ADJUNCT TO CORONARY ARTERIOGRAPHY IN DETECTING AND CONFIRMING THE COURSE OF CLINICALLY SIGNIFICANT CORONARY-ARTERY ANOMALIES

      The American journal of cardiology
    46. JUKEMA JW; ZWINDERMAN AH; VANBOVEN AJ; REIBER JHC; VANDERLAARSE A; LIE KI; BRUSCHKE AVG
      EVIDENCE FOR A SYNERGISTIC EFFECT OF CALCIUM-CHANNEL BLOCKERS WITH LIPID-LOWERING THERAPY IN RETARDING PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC PATIENTS WITH NORMAL TO MODERATELY RAISED CHOLESTEROL LEVELS

      Arteriosclerosis, thrombosis, and vascular biology
    47. TRESUKOSOL D; SCHALIJ MJ; SAVALLE LH; JUKEMA JW; BUIS B; REIBER JHC; BRUSCHKE AVG
      MICRO STENT(TM) QUANTITATIVE CORONARY ANGIOGRAPHY, AND PROCEDURAL RESULTS

      Catheterization and cardiovascular diagnosis
    48. JUKEMA JW; VANBOVEN AJ; GROENEMEYER B; ZWINDERMAN AH; REIBER JHC; BRUSCHKE AVG; HENNEMAN JA; MOLHOEK P; BRUIN T; GAGNE E; HAYDEN MR; KASTELEIN JJ
      LPL GENE MUTATION, CAUSING ONLY SUBTLE CHANGES IN PLASMA-LIPIDS, PROMOTES PROGRESSION OF CORONARY ATHEROSCLEROSIS WHICH CAN BE REVERSED BY PRAVASTATIN

      Circulation
    49. JUKEMA JW; VANBOVEN AJ; GROENEMEIJER B; ZWINDERMAN AH; REIBER JHC; BRUSCHKE AVG; HENNEMAN JA; MOLHOEK GP; BRUIN T; JANSEN H; GAGNE E; HAYDEN MR; KASTELEIN JJP
      THE ASP(9) ASN MUTATION IN THE LIPOPROTEIN-LIPASE GENE IS ASSOCIATED WITH INCREASED PROGRESSION OF CORONARY ATHEROSCLEROSIS

      Circulation
    50. VANBOVEN AJ; JUKEMA JW; ZWINDERMAN AH; CRIJNS HJGM; LIE KI; BRUSCHKE AVG
      REDUCTION OF TRANSIENT MYOCARDIAL-ISCHEMIA WITH PRAVASTATIN IN ADDITION TO THE CONVENTIONAL TREATMENT IN PATIENTS WITH ANGINA-PECTORIS

      Circulation
    51. JUKEMA JW; VANBOVEN AJ; ZWINDERMAN AH; BAL ET; REIBER JHC; BRUSCHKE AVG
      THE INFLUENCE OF ANGIOGRAPHIC END-POINTS ON THE OUTCOME OF LIPID INTERVENTION STUDIES - A PROPOSAL FOR STANDARDIZATION

      Angiology
    52. BYINGTON RP; JUKEMA JW; SALONEN JT; PITT B; BRUSCHKE AV; HOEN H; FURBERG CD; MANCINI J
      REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM

      Circulation
    53. JUKEMA JW; ZWINDERMAN AH; VANBOVEN AJ; REIBER JH; VANDERLAARSE A; BRUSCHKE AV
      EVIDENCE FOR A SYNERGISTIC EFFECT OF CALCIUM-CHANNEL BLOCKERS WITH LIPID-LOWERING THERAPY IN RETARDING PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC PATIENTS

      Circulation
    54. ZWINDERMAN AH; JUKEMA JW; VANBOVEN AJ; REIBER JH; BRUSCHKE AV
      A FUNCTIONAL STATISTICAL-MODEL FOR MODELING REPEATED QUANTITATIVE CORONARY ANGIOGRAPHY - EFFECTS OF TREATMENT, AND EXTENT OF DISEASE AT BASE-LINE

      Circulation
    55. JUKEMA JW; BRUSCHKE AVG; VANBOVEN AJ; REIBER JHC; BAL ET; ZWINDERMAN AH; JANSEN H; BOERMA GJM; VANRAPPARD FM; LIE KI
      EFFECTS OF LIPID-LOWERING BY PRAVASTATIN ON PROGRESSION AND REGRESSION OF CORONARY-ARTERY DISEASE IN SYMPTOMATIC MEN WITH NORMAL TO MODERATELY ELEVATED SERUM-CHOLESTEROL LEVELS - THE REGRESSION GROWTH EVALUATION STATIN STUDY (REGRESS)

      Circulation
    56. DEGROOT E; JUKEMA JW; VANBOVEN AJ; REIBER JHC; ZWINDERMAN AH; LIE KI; ACKERSTAFF RA; BRUSCHKE AVG
      EFFECT OF PRAVASTATIN ON PROGRESSION AND REGRESSION OF CORONARY ATHEROSCLEROSIS AND VESSEL WALL CHANGES IN CAROTID AND FEMORAL ARTERIES - AREPORT FROM THE REGRESSION GROWTH EVALUATION STATIN STUDY

      The American journal of cardiology
    57. VANBOVEN AJ; JUKEMA JW; CRIJNS HJGM; LIE KI
      HEART-RATE-VARIABILITY PROFILES IN SYMPTOMATIC CORONARY-ARTERY DISEASE AND PRESERVED LEFT-VENTRICULAR FUNCTION - RELATION TO VENTRICULAR-TACHYCARDIA AND TRANSIENT MYOCARDIAL-ISCHEMIA

      The American heart journal
    58. VANBOVEN AJ; JUKEMA JW; PAOLETTI R
      ENDOTHELIAL DYSFUNCTION AND DYSLIPIDEMIA - POSSIBLE EFFECTS OF LIPID-LOWERING AND LIPID MODIFYING THERAPY

      Pharmacological research
    59. VANBOVEN AJ; JUKEMA JW; BAL ET; REIBER JHC; BRUSCHKE AVG
      REMODELING OF CORONARY-ARTERY LESIONS - REGRESSION TO THE MEAN OR EFFECT OF CHOLESTEROL-LOWERING THERAPY

      Journal of the American College of Cardiology
    60. VANBOVEN AJ; JUKEMA JW; LIE KI; BRUSCHKE AVG
      INCIDENCE BUT NOT DURATION OF SILENT-MYOCARDIAL-ISCHEMIA CORRELATES WITH SEVERITY OF CORONARY-ARTERY DISEASE

      Journal of the American College of Cardiology
    61. JUKEMA JW; VANBOVEN JAJ; BAL ET; SARTORIUS OEH; VANRAPPARD FM; REIBER JHC; LIE KI; BRUSCHKE AVG
      THE IMPORTANCE OF CRITERIA SELECTED TO DEFINE PRO AND REGRESSION IN ANGIOGRAPHIC INTERVENTION TRIALS

      Journal of the American College of Cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:36:07